Founders were stuck between dilutive equity and slow banks.
A SaaS founder with $2M in ARR can be cash-poor and option-poor at the same time. Venture money costs equity and control. Banks don't understand recurring revenue, and take weeks of paperwork to maybe say no.
Founderpath had a thesis: a SaaS company's recurring revenue is one of the most predictable assets in finance. Read it accurately, in real time, and you can fund against it in hours, safely and without taking a slice of the company.
They needed a partner to turn that thesis into a product founders would trust with their financials, and that Founderpath could trust with their capital.


